Author Index Volume 6 (2016)
The issue number is given in front of the pagination
Aarsland, D., see Hessen, E. (2) 413-421
Aarsland, D., see Lee, J.H. (4) 733-739
Adler, C.H., see Beach, T.G. (1) 153-163
Adler, C.H., see Beach, T.G. (4) 761-770
Aerts, M.B., see Molenaar, J.P. (1) 53-55
Agosti, V., see Sorrentino, P. (1) 191-195
Ahmad, R., see Hossein-nezhad, A. (1) 109-117
Ahn, J., see Pagan, F. (3) 503-517
Akaike, A., see Izumi, Y. (3) 569-579
Alken, A.G., see Sidtis, J.J. (2) 361-370
Almendra, L., see Araújo, R. (4) 717-721
Alterman, R., see Sidtis, J.J. (2) 361-370
Alvariza, A., see Olsson, Y. (3) 581-587
Alzahrani, H., A. Antonini and A. Venneri, Apathy in Mild Parkinson’s Disease: Neuropsychological and Neuroimaging Evidence (4) 821-832
Antonini, A., see Alzahrani, H. (4) 821-832
Aparasu, R.R., see Chekani, F. (3) 617-624
Arai, T., see Hatsuta, H. (2) 325-334
Araújo, R., M. Tábuas-Pereira, L. Almendra, J. Ribeiro, M. Arenga, L. Negrão, A. Matos, A. Morgadinho and C. Januário, Tremor Frequency Assessment by iPhone® Applications: Correlation with EMG Analysis (4) 717-721
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016? (1) 57-63
Arenga, M., see Araújo, R. (4) 717-721
Ares, B., see Fernández-Pajarín, G. (4) 787-792
Årestedt, K., see Olsson, Y. (3) 581-587
Arizona Parkinson’s Disease Consortium see Beach, T.G. (1) 153-163
Asgharnejad, M., see Giladi, N. (2) 401-411
Asgharnejad, M., see Giladi, N. (4) 741-749
Atkinson, R.A., see Barnish, J. (3) 473-484
Atsuta, N., see Tanaka, Y. (4) 811-819
Auning, E., see Hessen, E. (2) 413-421
Baille, G., A.M. De Jesus, T. Perez, D. Devos, K. Dujardin, C.M. Charley, L. Defebvre and C. Moreau, Ventilatory Dysfunction in Parkinson’s Disease (3) 463-471
Bajaj, N.P., see Swallow, D.M.A. (2) 289-300
Bali, V., see Chekani, F. (3) 617-624
Ballanger, B., see Criaud, M. (2) 433-440
Ballard, C.G., see Lee, J.H. (4) 733-739
Baraduc, P., see Criaud, M. (2) 433-440
Barbato, A., see Sorrentino, P. (1) 191-195
Barker, R.A., M. Parmar, A. Kirkeby, A. Björklund, L. Thompson and P. Brundin
Barker, R.A., see Swallow, D.M.A. (2) 289-300
Barnish M.S., see Barnish, J. (3) 473-484
Barnish, J., R.A. Atkinson, S.M. Barran and M.S. Barnish, Potential Benefit of Singing for People with Parkinson’s Disease: A Systematic Review (3) 473-484
Barnish, M.S., D. Whibley, S.M.C. Horton, Z.R. Butterfint and K.H.O. Deane, Roles of Cognitive Status and Intelligibility in Everyday Communication in People with Parkinson’s Disease: A Systematic Review (3) 453-462
Barran, S.M., see Barnish, J. (3) 473-484
Barrett, M.J., A.F. Koeppel, J.L. Flanigan, S.D. Turner and B.B. Worrall, Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease Cognition (1) 119-124
Barthel, C., E. Mallia, B. Debû, B.R. Bloem and M.U. Ferraye, The Practicalities of Assessing Freezing of Gait (4) 667-674
Bauer, L., see Giladi, N. (2) 401-411
Bauer, L., see Giladi, N. (4) 741-749
Beach, T.G., A.-G. Corbille, F. Letournel, J.H. Kordower, T. Kremer, D.G. Munoz, A. Intorcia, J. Hentz, C.H. Adler, L.I. Sue, J. Walker, G. Serrano and P. Derkinderen, Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control Subjects (4) 761-770
Beach, T.G., C.H. Adler, G. Serrano, L.I. Sue, D.G. Walker, B.N. Dugger, H.A. Shill, E. Driver-Dunckley, J.N. Caviness, A. Intorcia, J. Filon, S. Scott, A. Garcia, B. Hoffman, C.M. Belden, K.J. Davis, M.N. Sabbagh and the Arizona Parkinson’s Disease Consortium, Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders (1) 153-163
Belden, C.M., see Beach, T.G. (1) 153-163
Ben-Shlomo, Y., see Swallow, D.M.A. (2) 289-300
Berendse, H.W., see Rimmelzwaan, L.M. (1) 29-37
Bhattacharjee, S., L. Goldstone and T. Warholak, Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease In Long Term Care Settings In The United States (1) 247-255
Bichon, A., see Lamberti, V.M.J. (1) 133-142
Bichon, A., see Rieu, I. (1) 267-277
Björklund, A., see Barker, R.A. (1) 57-63
Blake, C., see Kelly, B. (4) 709-716
Bloem, B.R., see Barthel, C. (4) 667-674
Bloem, B.R., see Hommel, A.L.A.J. (4) 805-810
Bloem, B.R., see Molenaar, J.P. (1) 53-55
Bloem, B.R., see Nijhuis, F.A.P. (3) 533-543
Blomsø, L., see Hessen, E. (2) 413-421
Böckmann, A., see Bousset, L. (1) 143-151
Boman, A., S. Svensson, A. Boxer, J.C. Rojas, W.W. Seeley, A. Karydas, B. Miller, K. Kågedal and P. Svenningsson, Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid (2) 307-315
Bonizzoni E., see Cattaneo, C. (1) 165-173
Booth, L., see Johnson, A.R. (3) 609-616
Bordelon, Y., see Paul, K.C. (2) 349-359
Boroojerdi, B., see Giladi, N. (2) 401-411
Boulinguez, P., see Criaud, M. (2) 433-440
Bourriez, J.-L., see Carriere, N. (3) 651-666
Bousset, L., P. Brundin, A. Böckmann, B. Meier and R. Melki, An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials (1) 143-151
Bouwyn, J.-P., S. Derrey, R. Lefaucheur, D. Fetter, A. Rouille, F. Le Goff and D. Maltête, Age Limits for Deep Brain Stimulation of Subthalamic Nuclei in Parkinson’s Disease (2) 393-400
Boxer, A., see Boman, A. (2) 307-315
Brady, S.T., see Kurowska, Z. (4) 703-707
Braybrook, M., S. O’Connor, P. Churchward, T. Perera, P. Farzanehfar and M. Horne, An Ambulatory Tremor Score for Parkinson’s Disease (4) 723-731
Brefel-Courbon, C., see Rieu, I. (1) 267-277
Bresolin, E., see van Uem, J.M.T. (2) 279-287
Bronstein, J.M., see Paul, K.C. (2) 349-359
Broussolle, E., see Criaud, M. (2) 433-440
Brundin, P., see Barker, R.A. (1) 57-63
Brundin, P., see Bousset, L. (1) 143-151
Brundin, P., see Kurowska, Z. (4) 703-707
Brundin, P., see Wyse, R.K. (3) 519-522
Bucks, R.S., see Johnson, A.R. (3) 609-616
Burke, R.E., see Kurowska, Z. (4) 703-707
Burke, R.E., see Tagliaferro, P. (1) 1-5
Burn, D.J., see Swallow, D.M.A. (2) 289-300
Butterfint, Z.R., see Barnish, M.S. (3) 453-462
Byrne, D.W., see Hacker, M.L. (1) 125-131
Cai, Q.-Q., see Wang, Z.-Y. (2) 317-323
Calejo, M., see Mendes, A. (4) 793-804
Canesi, M., M.L. Rusconi, F. Moroni, A. Ranghetti, E. Cereda and G. Pezzoli, Creative Thinking, Professional Artists, and Parkinson’s Disease (1) 239-246
Carlson, A., see Pagan, F. (3) 503-517
Carriere, N., J.-L. Bourriez, A. Delval, P. Derambure, L. Defebvre and K. Dujardin, Impulse Control Disorders in Parkinson’s Disease are Associated with Alterations in Reward-Related Cortical Oscillations (3) 651-666
Castrioto, A., see Lamberti, V.M.J. (1) 133-142
Castro, A., see Fernández-Pajarín, G. (4) 787-792
Cattaneo, C., M. Sardina and E. Bonizzoni, Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE (1) 165-173
Cavaco, S., see Mendes, A. (4) 793-804
Cavanaugh, J.T., see Paul, S.S. (2) 301-305
Caviness, J.N., see Beach, T.G. (1) 153-163
Cereda, E., see Canesi, M. (1) 239-246
Cervantes-Arriaga, A., see Rodríguez-Violante, M. (1) 183-190
Charles, D., see Hacker, M.L. (1) 125-131
Charley, C.M., see Baille, G. (3) 463-471
Chekani, F., V. Bali and R.R. Aparasu, Functional Status of Elderly Nursing Home Residents With Parkinson’s Disease (3) 617-624
Chen, C.P., see Lee, J.H. (4) 733-739
Chéreau, I., see Rieu, I. (1) 267-277
Cherif, M., see Jacobs, M.L. (1) 231-237
Cheung, V., see Mak, M.K.Y. (3) 639-650
Chodosh, J., see Fleisher, J.E. (2) 383-392
Choi, J.H., see Oh, Y.-S. (4) 771-778
Chu, W.C.W., see Mak, M.K.Y. (3) 639-650
Chu, Y., G.A. Morfini and J.H. Kordower, Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson’s Disease (1) 77-97
Chung, S.J., see Kim, H.J. (4) 675-683
Churchward, P., see Braybrook, M. (4) 723-731
Ciucci, M.R., see Jones, C.A. (1) 197-208
Claassen, D.O., see Herb, J.N. (2) 441-451
Clarén, L., see Olsson, Y. (3) 581-587
Conradsson, D., see Nero, H. (4) 833-840
Corbille, A.-G., see Beach, T.G. (4) 761-770
Corti, E.J., see Johnson, A.R. (3) 609-616
Creek, M.M., see Paul, K.C. (2) 349-359
Criaud, M., A. Poisson, S. Thobois, E. Metereau, J. Redouté, D. Ibarrola, P. Baraduc, E. Broussolle, A.P. Strafella, B. Ballanger and P. Boulinguez, Slowness in Movement Initiation is Associated with Proactive Inhibitory Network Dysfunction in Parkinson’s Disease (2) 433-440
Cubo, E., see Heldman, D.A. (3) 631-638
Currie, A.D., see Hacker, M.L. (1) 125-131
Dahodwala, N.A., see Fleisher, J.E. (2) 383-392
Damásio, J., see Mendes, A. (4) 793-804
Daneault, J.-F., see Lauzé, M. (4) 685-698
Dauvilliers, Y., see Jacobs, M.L. (1) 231-237
Davis, K.J., see Beach, T.G. (1) 153-163
Davis, T.L., see Hacker, M.L. (1) 125-131
Dawant, B.M., see Herb, J.N. (2) 441-451
De Bodt, M., see Martens, H. (1) 219-229
De Chazeron, I., see Rieu, I. (1) 267-277
De Jesus, A.M., see Baille, G. (3) 463-471
de Saráchaga, A.J., see Rodríguez-Violante, M. (1) 183-190
Deane K.H.O., see Barnish, M.S. (3) 453-462
Debû, B., see Barthel, C. (4) 667-674
Defebvre, L., see Baille, G. (3) 463-471
Defebvre, L., see Carriere, N. (3) 651-666
Delval, A., see Carriere, N. (3) 651-666
Derambure, P., see Carriere, N. (3) 651-666
Derkinderen, P., see Beach, T.G. (4) 761-770
Derrey, S., see Bouwyn, J.-P. (2) 393-400
Deuschl, G., see Margraf, N.G. (3) 485-501
Devos, D., see Baille, G. (3) 463-471
Dibble, L.E., see Paul, S.S. (2) 301-305
Dohin, E., see Giladi, N. (4) 741-749
Donahue, M.J., see Herb, J.N. (2) 441-451
Driver-Dunckley, E., see Beach, T.G. (1) 153-163
Du, G., see He, L. (3) 523-532
Du, G., see Sterling, N.W. (3) 557-567
Dugger, B.N., see Beach, T.G. (1) 153-163
Dujardin, K., see Baille, G. (3) 463-471
Dujardin, K., see Carriere, N. (3) 651-666
Dujardin, K., see Rieu, I. (1) 267-277
Dunn, C., see Pagan, F. (3) 503-517
Durif, F., see Lamberti, V.M.J. (1) 133-142
Durif, F., see Rieu, I. (1) 267-277
Duval, C., see Lauzé, M. (4) 685-698
Earhart, G.M., see Paul, S.S. (2) 301-305
Ebersbach, G., see Ossig, C. (3) 597-607
Eekhoff, E.M.W., see Rimmelzwaan, L.M. (1) 29-37
Eliassen, C.F., see Hessen, E. (2) 413-421
Ellis, T.D., see Paul, S.S. (2) 301-305
Eslinger, P.J., see He, L. (3) 523-532
Espay, A.J., see van Uem, J.M.T. (2) 279-287
Esselink, R.A., see Molenaar, J.P. (1) 53-55
Esselink, R.A.J., see Lamberti, V.M.J. (1) 133-142
Estrada-Bellmann, I., see Rodríguez-Violante, M. (1) 183-190
Evans, A., see Lee, W. (2) 371-382
Faber, M.J., see Hommel, A.L.A.J. (4) 805-810
Faber, M.J., see Nijhuis, F.A.P. (3) 533-543
Faghihi, M.A., see Hossein-nezhad, A. (1) 109-117
Falconer, R.A., see Pagan, F. (3) 503-517
Farzanehfar, P., see Braybrook, M. (4) 723-731
Fatemi, R.P., see Hossein-nezhad, A. (1) 109-117
Fauser, M., see Ossig, C. (3) 597-607
Fernandes, J., see Mendes, A. (4) 793-804
Fernández-Pajarín, G., Á. Sesar, B. Ares and A. Castro, Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study (4) 787-792
Ferraye, M.U., see Barthel, C. (4) 667-674
Fetter, D., see Bouwyn, J.-P. (2) 393-400
Fetter, D., see Rabel, C. (4) 779-785
Filon, J., see Beach, T.G. (1) 153-163
Fladby, T., see Hessen, E. (2) 413-421
Flanigan, J.L., see Barrett, M.J. (1) 119-124
Fleisher, J.E., N.A. Dahodwala, S.X. Xie, M. Mayo, D. Weintraub, J. Chodosh and J.A. Shea, Development and Validation of the Parkinson’s Disease Medication Beliefs Scale (PD-Rx) (2) 383-392
Foltynie, T., see Swallow, D.M.A. (2) 289-300
Ford, M.P., see Paul, S.S. (2) 301-305
Foreman, K.B., see Paul, S.S. (2) 301-305
Fraix, V., see Lamberti, V.M.J. (1) 133-142
Francis, P.T., see Lee, J.H. (4) 733-739
Franzén, E., see Nero, H. (4) 833-840
Fujimoto, Y., see Tanaka, Y. (4) 811-819
Futamura, A., see Murakami, H. (1) 209-217
Gagnon, J.-F., see Jacobs, M.L. (1) 231-237
Gandor, F., see Ossig, C. (3) 597-607
Garcia, A., see Beach, T.G. (1) 153-163
Gasser, T., Personalized Medicine Approaches in Parkinson’s Disease: The Genetic Perspective (4) 699-701
Gasson, N., see Johnson, A.R. (3) 609-616
Gaudio, L.D., see Sorrentino, P. (1) 191-195
Giladi, N., A.P. Nicholas, M. Asgharnejad, E. Dohin, F. Woltering, L. Bauer and W. Poewe, Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage (4) 741-749
Giladi, N., M. Asgharnejad, L. Bauer, F. Grieger and B. Boroojerdi, Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis (2) 401-411
Gilat, M., see Szeto, J.Y.Y. (3) 589-596
Giuffrida, J.P., see Heldman, D.A. (3) 631-638
Godfrey, A., see Hiorth, Y.H. (1) 175-182
Goff, F.L., see Rabel, C. (4) 779-785
Goldstone, L., see Bhattacharjee, S. (1) 247-255
Gonçalves, A., see Mendes, A. (4) 793-804
Grieger, F., see Giladi, N. (2) 401-411
Grosset, D.G., on behalf of PRoBaND Clinical Consortium, see Swallow, D.M.A. (2) 289-300
Grosset, K.A., see Swallow, D.M.A. (2) 289-300
Gu, Q., H. Zhang, M. Xuan, W. Luo, P. Huang, S. Xia and M. Zhang, Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson’s Disease (3) 545-556
Gunnery, S.D., B. Habermann, M. Saint-Hilaire, C.A. Thomas and L. Tickle-Degnen, The Relationship between the Experience of Hypomimia and Social Wellbeing in People with Parkinson’s Disease and their Care Partners (3) 625-630
Habermann, B., see Gunnery, S.D. (3) 625-630
Hacker, M.L., A.D. Currie, A.L. Molinari, M. Turchan, S.M. Millan, L.E. Heusinkveld, J. Roach, P.E. Konrad, T.L. Davis, J.S. Neimat, F.T. Phibbs, P. Hedera, D.W. Byrne and D. Charles, Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease (1) 125-131
Hagell, P., see Olsson, Y. (3) 581-587
Hagströmer, M., see Nero, H. (4) 833-840
Hallett, M., see Mak, M.K.Y. (3) 639-650
Hamberg, K., see Hariz, G.-M. (2) 335-347
Hansson, O., see Lindqvist, D. (1) 99-108
Hardy, J., see Swallow, D.M.A. (2) 289-300
Hariz, G.-M., P. Limousin and K. Hamberg, “DBS means everything – for some time”. Patients’ Perspectives on Daily Life with Deep Brain Stimulation for Parkinson’s Disease (2) 335-347
Hatsuta, H., M. Takao, Y. Nakano, A. Nogami, A. Uchino, H. Sumikura, K. Kanemaru, T. Arai, Y. Itoh and S. Murayama, Reduction of Small Fibers of Thoracic Ventral Roots and Neurons of Intermediolateral Nucleus in Parkinson Disease and Dementia with Lewy Bodies (2) 325-334
He, L., E.-Y. Lee, N.W. Sterling, L. Kong, M.M. Lewis, G. Du, P.J. Eslinger and X. Huang, The Key Determinants to Quality of Life in Parkinson’s Disease Patients: Results from the Parkinson’s Disease Biomarker Program (PDBP) (3) 523-532
Hebron, M., see Pagan, F. (3) 503-517
Hedera, P., see Hacker, M.L. (1) 125-131
Hedera, P., see Herb, J.N. (2) 441-451
Heldman, D.A., J.P. Giuffrida and E. Cubo, Wearable Sensors for Advanced Therapy Referral in Parkinson’s Disease (3) 631-638
Hentz, J., see Beach, T.G. (4) 761-770
Herb, J.N., S. Rane, D.A. Isaacs, N.V. Wouwe, O.C. Roman, B.A. Landman, B.M. Dawant, P. Hedera, D.H. Zald, J.S. Neimat, S.A. Wylie, M.J. Donahue and D.O. Claassen, Cortical Implications of Advancing Age and Disease Duration in Parkinson’s Disease Patients with Postural Instability and Gait Dysfunction (2) 441-451
Hessen, E., A.L. Stav, E. Auning, P. Selnes, L. Blomsø, C.E. Holmeide, K.K. Johansen, C.F. Eliassen, I. Reinvang, T. Fladby and D. Aarsland, Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases (2) 413-421
Heusinkveld, L.E., see Hacker, M.L. (1) 125-131
Hiorth, Y.H., J.P. Larsen, K. Lode, O.-B. Tysnes, A. Godfrey, S. Lord, L. Rochester and K.F. Pedersen, Impact of Falls on Physical Activity in People with Parkinson’s Disease (1) 175-182
Hirayama, M., M. Tsunoda, M. Yamamoto, T. Tsuda and K. Ohno, Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson’s Disease (2) 423-431
Hoffman, B., see Beach, T.G. (1) 153-163
Holmeide, C.E., see Hessen, E. (2) 413-421
Hommel, A.L.A.J., M.J. Faber, N.J. Weerkamp, J.G. van Dijk, B.R. Bloem and R.T. Koopmans, Prevalence and Prescribed Treatments of Orthostatic Hypotension in Institutionalized Patients with Parkinson’s Disease (4) 805-810
Horne, M., see Braybrook, M. (4) 723-731
Horton,S.M.C., see Barnish, M.S. (3) 453-462
Hossein-nezhad, A., R.P. Fatemi, R. Ahmad, E.R. Peskind, C.P. Zabetian, S.-C. Hu, M. Shi, C. Wahlestedt, J. Zhang and M.A. Faghihi, Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease (1) 109-117
Houeto, J.L., see Rieu, I. (1) 267-277
Howard, H., see Pagan, F. (3) 503-517
Hu, S.-C., see Hossein-nezhad, A. (1) 109-117
Huang, P., see Gu, Q. (3) 545-556
Huang, X., see He, L. (3) 523-532
Huang, X., see Pagan, F. (3) 503-517
Huang, X., see Sterling, N.W. (3) 557-567
Ibarrola, D., see Criaud, M. (2) 433-440
Intorcia, A., see Beach, T.G. (1) 153-163
Intorcia, A., see Beach, T.G. (4) 761-770
Isaacs, D.A., see Herb, J.N. (2) 441-451
Isaacs, T., see van Uem, J.M.T. (2) 279-287
Isaacson, S., H.A. Shill, S. Vernino, A. Ziemann and G.J. Rowse, Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303) (4) 751-759
Ishigaki, S., see Murakami, H. (1) 209-217
Ito, M., see Tanaka, Y. (4) 811-819
Itoh, Y., see Hatsuta, H. (2) 325-334
Izumi, Y., N. Kondo, R. Takahashi, A. Akaike and T. Kume, Reduction of Immunoreactivity Against the C-Terminal Region of the Intracellular α-Synuclein by Exogenous α-Synuclein Aggregates: Possibility of Conformational Changes (3) 569-579
Jacobs, M.L., Y. Dauvilliers, E.K. St. Louis, S.J. McCarter, S.R. Romenets, A. Pelletier, M. Cherif, J.-F. Gagnon and R.B. Postuma, Risk Factor Profile in Parkinson’s Disease Subtype with REM Sleep Behavior Disorder (1) 231-237
Janszky, J., see Weintraut, R. (1) 257-265
Januário, C., see Araújo, R. (4) 717-721
Jenner, P., see Stamford, J. (1) 65-66
Jeon, B., see Kim, H.J. (4) 675-683
Johansen, K.K., see Hessen, E. (2) 413-421
Johnson, A.R., B.J. Lawrence, E.J. Corti, L. Booth, N. Gasson, M.G. Thomas, A.M. Loftus and R.S. Bucks, Suitability of the Depression, Anxiety, and Stress Scale in Parkinson’s Disease (3) 609-616
Jones, C.A. and M.R. Ciucci, Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease (1) 197-208
Jost, W.H., see Ossig, C. (3) 597-607
Kågedal, K., see Boman, A. (2) 307-315
Kajita, Y., see Tanaka, Y. (4) 811-819
Kalaria, R.N., see Lee, J.H. (4) 733-739
Kanemaru, K., see Hatsuta, H. (2) 325-334
Karádi, K., see Weintraut, R. (1) 257-265
Karydas, A., see Boman, A. (2) 307-315
Katoh, H., see Murakami, H. (1) 209-217
Katsuno, M., see Tanaka, Y. (4) 811-819
Kawamura, M., see Murakami, H. (1) 209-217
Kelly, B., C. Blake and O. Lennon, Acute Hospital Admissions of Individuals with a Known Parkinson’s Disease Diagnosis in Ireland 2009–2012: A Short Report (4) 709-716
Kezuka, M., see Murakami, H. (1) 209-217
Kim, H.J., B. Jeon and S.J. Chung, Professional ethics in complementary and alternative medicines in management of Parkinson’s disease (4) 675-683
Kirkeby, A., see Barker, R.A. (1) 57-63
Kistner, A., see Lamberti, V.M.J. (1) 133-142
Koeppel, A.F., see Barrett, M.J. (1) 119-124
Kondo, N., see Izumi, Y. (3) 569-579
Kong, L., see He, L. (3) 523-532
Konrad, P.E., see Hacker, M.L. (1) 125-131
Koopmans, R.T., see Hommel, A.L.A.J. (4) 805-810
Kordower, J.H., see Beach, T.G. (4) 761-770
Kordower, J.H., see Chu, Y. (1) 77-97
Kordower, J.H., see Kurowska, Z. (4) 703-707
Kovács, M., see Weintraut, R. (1) 257-265
Kovács, N., see Weintraut, R. (1) 257-265
Krack, P., see Lamberti, V.M.J. (1) 133-142
Krack, P., see Mendes, A. (4) 793-804
Krack, P., see Rieu, I. (1) 267-277
Kremer, T., see Beach, T.G. (4) 761-770
Kume, T., see Izumi, Y. (3) 569-579
Kurowska, Z., J.H. Kordower, A.J. Stoessl, R.E. Burke, P. Brundin, Z. Yue, S.T. Brady, J. Milbrandt, B.D. Trapp, T.B. Sherer and S. Medicetty, Is Axonal Degeneration a Key Early Event in Parkinson’s Disease? (4) 703-707
Kwon, D.-Y., see Oh, Y.-S. (4) 771-778
Lai, M.K.P., see Lee, J.H. (4) 733-739
Lamberti, V.M.J., B. Pereira, E. Lhommée, A. Bichon, E. Schmitt, P. Pelissier, A. Kistner, V. Fraix, A. Castrioto, R.A.J. Esselink, F. Durif and P. Krack, Profile of Neuropsychiatric Symptoms in Parkinson’s Disease: Surgical Candidates Compared to Controls (1) 133-142
Landman, B.A., see Herb, J.N. (2) 441-451
Larsen, J.P., see Hiorth, Y.H. (1) 175-182
Lauzé, M., J.-F. Daneault and C. Duval, The Effects of Physical Activity in Parkinson’s Disease: A Review (4) 685-698
Lawler, A., see Pagan, F. (3) 503-517
Lawrence, B.J., see Johnson, A.R. (3) 609-616
Lawton, M.A., see Swallow, D.M.A. (2) 289-300
Le Goff, F., see Bouwyn, J.-P. (2) 393-400
Leal-Ortega, R., see Rodríguez-Violante, M. (1) 183-190
Lee, E.-Y., see He, L. (3) 523-532
Lee, J.H., P.T. Francis, C.G. Ballard, D. Aarsland, R.N. Kalaria, P.T.-H. Wong, C.P. Chen and M.K.P. Lai, Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson’s Disease Dementia (4) 733-739
Lee, W., A. Evans and D.R. Williams, Validation of a Smartphone Application Measuring Motor Function in Parkinson’s Disease (2) 371-382
Lefaucheur, R., see Bouwyn, J.-P. (2) 393-400
Lefaucheur, R., see Rabel, C. (4) 779-785
Leijten, Q.H., see Molenaar, J.P. (1) 53-55
Lennon, O., see Kelly, B. (4) 709-716
Letournel, F., see Beach, T.G. (4) 761-770
Lewin, A., see van Uem, J.M.T. (2) 279-287
Lewis, M.M., see He, L. (3) 523-532
Lewis, M.M., see Sterling, N.W. (3) 557-567
Lewis, S.J.G., see Szeto, J.Y.Y. (3) 589-596
Lhommée, E., see Lamberti, V.M.J. (1) 133-142
Li, Z., see Pagan, F. (3) 503-517
Lian, H., see Wang, Z.-Y. (2) 317-323
Lima, A.B., see Mendes, A. (4) 793-804
Limousin, P., see Hariz, G.-M. (2) 335-347
Lindqvist, D., I. Prokopenko, E. Londos, L. Middleton and O. Hansson, Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism (1) 99-108
Lips, P., see Rimmelzwaan, L.M. (1) 29-37
Lode, K., see Hiorth, Y.H. (1) 175-182
Loftus, A.M., see Johnson, A.R. (3) 609-616
Londos, E., see Lindqvist, D. (1) 99-108
Lord, S., see Hiorth, Y.H. (1) 175-182
Lou, W., see Mak, M.K.Y. (3) 639-650
Lu, Z.L., see Mak, M.K.Y. (3) 639-650
Lucza, T., see Weintraut, R. (1) 257-265
Luo, W., see Gu, Q. (3) 545-556
Ma, S., see Mak, M.K.Y. (3) 639-650
Maetzler, W., see van Uem, J.M.T. (2) 279-287
Mak, M.K.Y., V. Cheung, S. Ma, Z.L. Lu, D. Wang, W. Lou, L. Shi, V.C.T. Mok, W.C.W. Chu and M. Hallett, Increased Cognitive Control During Execution of Finger Tap Movement in People with Parkinson’s Disease (3) 639-650
Makkos, A., see Weintraut, R. (1) 257-265
Malek, N., see Swallow, D.M.A. (2) 289-300
Mallia, E., see Barthel, C. (4) 667-674
Maltête, D., see Bouwyn, J.-P. (2) 393-400
Maltête, D., see Rabel, C. (4) 779-785
Margraf, N.G., A. Wrede, G. Deuschl and W.J. Schulz-Schaeffer, Pathophysiological Concepts and Treatment of Camptocormia (3) 485-501
Martens, H., G.V. Nuffelen, K. Wouters and M. De Bodt, Reception of Communicative Functions of Prosody in Hypokinetic Dysarthria due to Parkinson’s Disease (1) 219-229
Martin, I., Decoding Parkinson’s Disease Pathogenesis: The Role of Deregulated mRNA Translation (1) 17-27
Matos, A., see Araújo, R. (4) 717-721
Matthews, H., see van Uem, J.M.T. (2) 279-287
Mayo, M., see Fleisher, J.E. (2) 383-392
McCarter, S.J., see Jacobs, M.L. (1) 231-237
Medicetty, S., see Kurowska, Z. (4) 703-707
Meier, B., see Bousset, L. (1) 143-151
Melki, R., see Bousset, L. (1) 143-151
Mendes, A., A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Teixeira-Pinto, P. Krack, A.B. Lima and S. Cavaco, Statistical Models of Parkinson’s Disease Progression: Predictive Validity in a 3-Year Follow-up (4) 793-804
Metereau, E., see Criaud, M. (2) 433-440
Middleton, L., see Lindqvist, D. (1) 99-108
Milbrandt, J., see Kurowska, Z. (4) 703-707
Millan, S.M., see Hacker, M.L. (1) 125-131
Millán-Cepeda, R., see Rodríguez-Violante, M. (1) 183-190
Miller, B., see Boman, A. (2) 307-315
Miller, M.W., see Murakami, H. (1) 209-217
Mills, R.R., see Pagan, F. (3) 503-517
Mok, V.C.T., see Mak, M.K.Y. (3) 639-650
Molenaar, J.P., J. Wilbers, M.B. Aerts, Q.H. Leijten, J.G. van Dijk, R.A. Esselink and B.R. Bloem, Sudden Death: An Uncommon Occurrence in Dementia with Lewy Bodies (1) 53-55
Molinari, A.L., see Hacker, M.L. (1) 125-131
Momma, Y., see Murakami, H. (1) 209-217
Moreau, C., see Baille, G. (3) 463-471
Moreira, I., see Mendes, A. (4) 793-804
Morfini, G.A., see Chu, Y. (1) 77-97
Morgadinho, A., see Araújo, R. (4) 717-721
Mori, Y., see Murakami, H. (1) 209-217
Moroni, F., see Canesi, M. (1) 239-246
Morris, H.R., see Swallow, D.M.A. (2) 289-300
Moussa, C., see Pagan, F. (3) 503-517
Mowszowski, L., see Szeto, J.Y.Y. (3) 589-596
Munoz, D.G., see Beach, T.G. (4) 761-770
Murakami, H., Y. Momma, T. Nohara, Y. Mori, A. Futamura, T. Sugita, S. Ishigaki, H. Katoh, M. Kezuka, K. Ono, M.W. Miller and M. Kawamura, Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson’s Disease Patients Taking Dopaminergic Medication (1) 209-217
Murayama, S., see Hatsuta, H. (2) 325-334
Naismith, S.L., see Szeto, J.Y.Y. (3) 589-596
Nakano, Y., see Hatsuta, H. (2) 325-334
Nakatsubo, D., see Tanaka, Y. (4) 811-819
Negrão, L., see Araújo, R. (4) 717-721
Neimat, J.S., see Hacker, M.L. (1) 125-131
Neimat, J.S., see Herb, J.N. (2) 441-451
Nero, H., M.B. Wallén, E. Franzén, D. Conradsson, A. Ståhle and M. Hagströmer, Objectively Assessed Physical Activity and its Association with Balance, Physical Function and Dyskinesia in Parkinson’s Disease (4) 833-840
Nicholas, A.P., see Giladi, N. (4) 741-749
Nijhuis, F.A.P., J. van Heek, B.R. Bloem, B. Post and M.J. Faber, Choosing an Advanced Therapy in Parkinson’s Disease; is it an Evidence-Based Decision in Current Practice? (3) 533-543
Nogami, A., see Hatsuta, H. (2) 325-334
Nohara, T., see Murakami, H. (1) 209-217
Nuffelen, G.V., see Martens, H. (1) 219-229
O’Connor, S., see Braybrook, M. (4) 723-731
Oh, Y.-S., J.H. Choi and D.-Y. Kwon, Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function (4) 771-778
Ohdake, R., see Tanaka, Y. (4) 811-819
Ohno, K., see Hirayama, M. (2) 423-431
Olsson, Y., L. Clarén, A. Alvariza, K. Årestedt and P. Hagell, Health and Social Service Access Among Family Caregivers of People with Parkinson’s Disease (3) 581-587
Ono, K., see Murakami, H. (1) 209-217
Ory-Magne, F., see Rieu, I. (1) 267-277
Ossig, C., D. Sippel, M. Fauser, F. Gandor, W.H. Jost, G. Ebersbach and A. Storch, Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson’s Disease (3) 597-607
Oueslati, A., Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? (1) 39-51
Ozel, G., see Rabel, C. (4) 779-785
Pagan, F., M. Hebron, E.H. Valadez, Y. Torres-Yaghi, X. Huang, R.R. Mills, B.M. Wilmarth, H. Howard, C. Dunn, A. Carlson, A. Lawler, S.L. Rogers, R.A. Falconer, J. Ahn, Z. Li and C. Moussa, Nilotinib Effects in Parkinson’s Disease and Dementia with Lewy Bodies (3) 503-517
Parmar, M., see Barker, R.A. (1) 57-63
Paul, K.C., R. Rausch, M.M. Creek, J.S. Sinsheimer, J.M. Bronstein, Y. Bordelon and B. Ritz, APOE, MAPT, and COMT and Parkinson’s Disease Susceptibility and Cognitive Symptom Progression (2) 349-359
Paul, S.S., T.D. Ellis, L.E. Dibble, G.M. Earhart, M.P. Ford, K.B. Foreman and J.T. Cavanaugh, Obtaining Reliable Estimates of Ambulatory Physical Activity in People with Parkinson’s Disease (2) 301-305
Pedersen, K.F., see Hiorth, Y.H. (1) 175-182
Pelissier, P., see Lamberti, V.M.J. (1) 133-142
Pelletier, A., see Jacobs, M.L. (1) 231-237
Pereira, B., see Lamberti, V.M.J. (1) 133-142
Pereira, B., see Rieu, I. (1) 267-277
Perera, T., see Braybrook, M. (4) 723-731
Perez, T., see Baille, G. (3) 463-471
Peskind, E.R., see Hossein-nezhad, A. (1) 109-117
Pezzoli G., see Canesi, M. (1) 239-246
Phibbs, F.T., see Hacker, M.L. (1) 125-131
Poewe, W., see Giladi, N. (4) 741-749
Poisson, A., see Criaud, M. (2) 433-440
Post, B., see Nijhuis, F.A.P. (3) 533-543
Postuma, R.B., see Jacobs, M.L. (1) 231-237
Prokopenko, I., see Lindqvist, D. (1) 99-108
Rabel, C., F.L. Goff, R. Lefaucheur, G. Ozel, D. Fetter, A. Rouillé and D. Maltête, Subjective Perceived Motor Improvement after Acute Levodopa Challenge in Parkinson’s Disease (4) 779-785
Rane, S., see Herb, J.N. (2) 441-451
Ranghetti, A., see Canesi, M. (1) 239-246
Rausch, R., see Paul, K.C. (2) 349-359
Redouté, J., see Criaud, M. (2) 433-440
Reinvang, I., see Hessen, E. (2) 413-421
Ribeiro, J., see Araújo, R. (4) 717-721
Rieu, I., J.L. Houeto, B. Pereira, I. De Chazeron, A. Bichon, I. Chéreau, M. Ulla, C. Brefel-Courbon, F. Ory-Magne, K. Dujardin, F. Tison, P. Krack and F. Durif, Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson’s disease (1) 267-277
Rimmelzwaan, L.M., N.M. van Schoor, P. Lips, H.W. Berendse and E.M.W. Eekhoff, Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease (1) 29-37
Ritz, B., see Paul, K.C. (2) 349-359
Roach, J., see Hacker, M.L. (1) 125-131
Rochester, L., see Hiorth, Y.H. (1) 175-182
Rodríguez-Violante, M., A.J. de Saráchaga, A. Cervantes-Arriaga, R. Millán-Cepeda, R. Leal-Ortega, I. Estrada-Bellmann and C. Zuñiga-Ramírez, Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson’s Disease: A Retrospective Study (1) 183-190
Rogers, S.L., see Pagan, F. (3) 503-517
Rojas, J.C., see Boman, A. (2) 307-315
Roman, O.C., see Herb, J.N. (2) 441-451
Romenets, S.R., see Jacobs, M.L. (1) 231-237
Rouille, A., see Bouwyn, J.-P. (2) 393-400
Rouillé, A., see Rabel, C. (4) 779-785
Rowse, G.J., see Isaacson, S. (4) 751-759
Rucco, R., see Sorrentino, P. (1) 191-195
Rusconi, M.L., see Canesi, M. (1) 239-246
Sabbagh, M.N., see Beach, T.G. (1) 153-163
Saint-Hilaire, M., see Gunnery, S.D. (3) 625-630
Salkovic, D., see van Uem, J.M.T. (2) 279-287
Sardina, M., see Cattaneo, C. (1) 165-173
Scheller, D., see Stamford, J. (1) 65-66
Schmitt, E., see Lamberti, V.M.J. (1) 133-142
Schulz-Schaeffer, W.J., see Margraf, N.G. (3) 485-501
Scott, S., see Beach, T.G. (1) 153-163
Seeley, W.W., see Boman, A. (2) 307-315
Selnes, P., see Hessen, E. (2) 413-421
Serrano, G., see Beach, T.G. (1) 153-163
Serrano, G., see Beach, T.G. (4) 761-770
Sesar, Á., see Fernández-Pajarín, G. (4) 787-792
Shea, J.A., see Fleisher, J.E. (2) 383-392
Sherer, T.B., see Kurowska, Z. (4) 703-707
Sherer, T.B., see Wyse, R.K. (3) 519-522
Shi, L., see Mak, M.K.Y. (3) 639-650
Shi, M., see Hossein-nezhad, A. (1) 109-117
Shill, H.A., see Beach, T.G. (1) 153-163
Shill, H.A., see Isaacson, S. (4) 751-759
Sibilio, M., see Sorrentino, P. (1) 191-195
Sidtis, D.V.L., see Sidtis, J.J. (2) 361-370
Sidtis, J.J., A.G. Alken, M. Tagliati, R. Alterman and D.V.L. Sidtis, Subthalamic Stimulation Reduces Vowel Space at the Initiation of Sustained Production: Implications for Articulatory Motor Control in Parkinson’s Disease (2) 361-370
Sinsheimer, J.S., see Paul, K.C. (2) 349-359
Sippel, D., see Ossig, C. (3) 597-607
Smith, C.R., see Swallow, D.M.A. (2) 289-300
Sobue, G., see Tanaka, Y. (4) 811-819
Sorrentino, G., see Sorrentino, P. (1) 191-195
Sorrentino, P., A. Barbato, L.D. Gaudio, R. Rucco, P. Varriale, M. Sibilio, P. Strazzullo, G. Sorrentino and V. Agosti, Impaired gait kinematics in type 1 Gaucher’s Disease (1) 191-195
St. Louis, E.K., see Jacobs, M.L. (1) 231-237
Ståhle, A., see Nero, H. (4) 833-840
Stamford, J., D. Scheller and P. Jenner, Parkinson’s Inside Out (1) 65-66
Stav, A.L., see Hessen, E. (2) 413-421
Stenberg, G., Impulse Control Disorders – The Continuum Hypothesis (1) 67-75
Sterling, N.W., M.M. Lewis, G. Du and X. Huang, Structural Imaging and Parkinson’s Disease: Moving Toward Quantitative Markers of Disease Progression (3) 557-567
Sterling, N.W., see He, L. (3) 523-532
Stoessl, A.J., see Kurowska, Z. (4) 703-707
Storch, A., see Ossig, C. (3) 597-607
Strafella, A.P., see Criaud, M. (2) 433-440
Strazzullo, P., see Sorrentino, P. (1) 191-195
Sue, L.I., see Beach, T.G. (1) 153-163
Sue, L.I., see Beach, T.G. (4) 761-770
Sugita, T., see Murakami, H. (1) 209-217
Sumikura, H., see Hatsuta, H. (2) 325-334
Svenningsson, P., see Boman, A. (2) 307-315
Svensson, S., see Boman, A. (2) 307-315
Swallow, D.M.A., M.A. Lawton, K.A. Grosset, N. Malek, C.R. Smith, N.P. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N. Williams, N.W. Wood and D.G. Grosset on behalf of PRoBaND Clinical Consortium, Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection (2) 289-300
Szeto, J.Y.Y., L. Mowszowski, M. Gilat, C.C. Walton, S.L. Naismith and S.J.G. Lewis, Mild Cognitive Impairment in Parkinson’s Disease: Impact on Caregiver Outcomes (3) 589-596
Tábuas-Pereira, M., see Araújo, R. (4) 717-721
Tagliaferro, P. and R.E. Burke, Retrograde Axonal Degeneration in Parkinson Disease (1) 1-5
Tagliati, M., see Sidtis, J.J. (2) 361-370
Takahashi, R., see Izumi, Y. (3) 569-579
Takao, M., see Hatsuta, H. (2) 325-334
Tanaka, Y., T. Tsuboi, H. Watanabe, Y. Kajita, D. Nakatsubo, Y. Fujimoto, R. Ohdake, M. Ito, N. Atsuta, M. Yamamoto, T. Wakabayashi, M. Katsuno and G. Sobue, Articulation Features of Parkinson’s Disease Patients with Subthalamic Nucleus Deep Brain Stimulation (4) 811-819
Teixeira-Pinto, A., see Mendes, A. (4) 793-804
Thobois, S., see Criaud, M. (2) 433-440
Thomas, C.A., see Gunnery, S.D. (3) 625-630
Thomas, M.G., see Johnson, A.R. (3) 609-616
Thompson, L., see Barker, R.A. (1) 57-63
Tickle-Degnen, L., see Gunnery, S.D. (3) 625-630
Tison, F., see Rieu, I. (1) 267-277
Torres-Yaghi, Y., see Pagan, F. (3) 503-517
Trapp, B.D., see Kurowska, Z. (4) 703-707
Tsuboi, T., see Tanaka, Y. (4) 811-819
Tsuda, T., see Hirayama, M. (2) 423-431
Tsunoda, M., see Hirayama, M. (2) 423-431
Turchan, M., see Hacker, M.L. (1) 125-131
Turner, S.D., see Barrett, M.J. (1) 119-124
Tysnes, O.-B., see Hiorth, Y.H. (1) 175-182
Uchino, A., see Hatsuta, H. (2) 325-334
Ulla, M., see Rieu, I. (1) 267-277
Valadez, E.H., see Pagan, F. (3) 503-517
van Dijk, J.G., see Hommel, A.L.A.J. (4) 805-810
van Dijk, J.G., see Molenaar, J.P. (1) 53-55
van Heek, J., see Nijhuis, F.A.P. (3) 533-543
van Schoor, N.M., see Rimmelzwaan, L.M. (1) 29-37
van Uem, J.M.T., T. Isaacs, A. Lewin, E. Bresolin, D. Salkovic, A.J. Espay, H. Matthews and W. Maetzler, A Viewpoint on Wearable Technology-Enabled Measurement of Wellbeing and Health-Related Quality of Life in Parkinson’s Disease (2) 279-287
Varriale, P., see Sorrentino, P. (1) 191-195
Venneri, A., see Alzahrani, H. (4) 821-832
Vernino, S., see Isaacson, S. (4) 751-759
Vila-Chã, N., see Mendes, A. (4) 793-804
Wahlestedt, C., see Hossein-nezhad, A. (1) 109-117
Wakabayashi, T., see Tanaka, Y. (4) 811-819
Walker, D.G., see Beach, T.G. (1) 153-163
Walker, J., see Beach, T.G. (4) 761-770
Wallén, M.B., see Nero, H. (4) 833-840
Walton, C.C., see Szeto, J.Y.Y. (3) 589-596
Wang, D., see Mak, M.K.Y. (3) 639-650
Wang, Z.-Y., H. Lian, L. Zhou, Y.-M. Zhang, Q.-Q. Cai, L.-F. Zheng and J.-X. Zhu, Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson’s Disease Rat Model (2) 317-323
Warholak, T., see Bhattacharjee, S. (1) 247-255
Watanabe, H., see Tanaka, Y. (4) 811-819
Weerkamp, N.J., see Hommel, A.L.A.J. (4) 805-810
Weintraub, D., see Fleisher, J.E. (2) 383-392
Weintraut, R., K. Karádi, T. Lucza, M. Kovács, A. Makkos, J. Janszky and N. Kovács, Lille Apathy Rating Scale and MDS-UPDRS for Screening Apathy in Parkinson’s Disease (1) 257-265
Whibley, D., see Barnish, M.S. (3) 453-462
Wilbers, J., see Molenaar, J.P. (1) 53-55
Williams, D.R., see Lee, W. (2) 371-382
Williams, N., see Swallow, D.M.A. (2) 289-300
Wilmarth, B.M., see Pagan, F. (3) 503-517
Woltering, F., see Giladi, N. (4) 741-749
Wong, P.T.-H., see Lee, J.H. (4) 733-739
Wood, N.W., see Swallow, D.M.A. (2) 289-300
Worrall, B.B., see Barrett, M.J. (1) 119-124
Wouters, K., see Martens, H. (1) 219-229
Wouwe, N.V., see Herb, J.N. (2) 441-451
Wrede, A., see Margraf, N.G. (3) 485-501
Wylie, S.A., see Herb, J.N. (2) 441-451
Wyse, R.K., P. Brundin and T.B. Sherer, Nilotinib – Differentiating the Hope from the Hype (3) 519-522
Xia, S., see Gu, Q. (3) 545-556
Xie, S.X., see Fleisher, J.E. (2) 383-392
Xuan, M., see Gu, Q. (3) 545-556
Yamamoto, M., see Hirayama, M. (2) 423-431
Yamamoto, M., see Tanaka, Y. (4) 811-819
Yue, Z., see Kurowska, Z. (4) 703-707
Zabetian, C.P., see Hossein-nezhad, A. (1) 109-117
Zald, D.H., see Herb, J.N. (2) 441-451
Zhang, H., see Gu, Q. (3) 545-556
Zhang, J., see Hossein-nezhad, A. (1) 109-117
Zhang, M., see Gu, Q. (3) 545-556
Zhang, Y.-M., see Wang, Z.-Y. (2) 317-323
Zheng, L.-F., see Wang, Z.-Y. (2) 317-323
Zhou, L., see Wang, Z.-Y. (2) 317-323
Zhu, J.-X., see Wang, Z.-Y. (2) 317-323
Ziemann, A., see Isaacson, S. (4) 751-759
Zuñiga-Ramírez, C., see Rodríguez-Violante, M. (1) 183-190
